Cardiac sympathetic innervation and PGP9.5 expression by cardiomyocytes after myocardial infarction: Effects of central MR blockade

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 305, Issue 12, 2013, Pages

  Drobysheva, Anastasia ^a   Ahmad, Monir ^a   White, Roselyn ^a   Wang, Hong Wei ^a   Leenen, Frans H H ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Brain mineralocorticoid receptors; Cardiac sympathetic hyperinnervation; Eplerenone; Myocardial infarction; Protein gene product 9.5; Ubiquitin

Indexed keywords

EPLERENONE; MINERALOCORTICOID RECEPTOR; NEUROMODULIN; NORADRENALIN TRANSPORTER; TYROSINE 3 MONOOXYGENASE; UBIQUITIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; COMPARATIVE STUDY; CONTROLLED STUDY; GENE ACTIVATION; GENE OVEREXPRESSION; GENE PRODUCT; GENETIC ASSOCIATION; HEART; HEART INFARCTION; HEART MUSCLE CELL; MALE; NERVE SPROUTING; NONHUMAN; PRIORITY JOURNAL; RAT; SYMPATHETIC INNERVATION;

EID: 84890338079     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00445.2013     Document Type: Article

References (53)

1. Batulevicius D, Pauziene N, Pauza DH. Architecture and age-related analysis of the neuronal number of the guinea pig intrinsic cardiac nerve plexus. Ann Anat 187: 225-243, 2005.
2. Bobrovskaya L, Gilligan C, Bolster EK, Flaherty JJ, Dickson PW, Dunkley PR. Sustained phosphorylation of tyrosine hydroxylase at serine 40: a novel mechanism for maintenance of catecholamine synthesis. J Neurochem 100: 479-489, 2007.
3. Burgi K, Cavalleri MT, Alves AS, Britto LR, Antunes VR, Michelini LC. Tyrosine hydroxylase immunoreactivity as indicator of sympathetic activity: simultaneous evaluation in different tissues of hypertensive rats. Am J Physiol Regul Integr Comp Physiol 300: R264-R271, 2011.
4. Chen PS, Chen LS, Cao JM, Sharifi B, Karagueuzian HS, Fishbein MC. Sympathetic nerve sprouting, electrical remodeling and the mechanisms of sudden cardiac death. Cardiovasc Res 50: 409-416, 2001.
5. Colucci WS, Sawyer DB, Singh K, Communal C. Adrenergic overload and apoptosis in heart failure: implications for therapy. J Card Fail 6: 1-7, 2000.
6. Drapeau J, El-Helou V, Clement R, Bel-Hadj S, Gosselin H, Trudeau LE, Calderone A. Nestin-expressing neural stem cells identified in the scar following myocardial infarction. J Cell Physiol 204: 51-62, 2005.
7. Dunkley PR, Bobrovskaya L, Graham ME, von Nagy-Felsobuki E.I, Dickson PW. Tyrosine hydroxylase phosphorylation: regulation and consequences. J Neurochem 91: 1025-1043, 2004.
8. El-Helou V, Proulx C, Gosselin H, Clement R, Mimee A, Villeneuve L, Calderone A. Dexamethasone treatment of post-MI rats attenuates sympathetic innervation of the infarct region. J Appl Physiol 104: 150-156, 2008.
9. Fang Y, Fu D, Shen XZ. The potential role of ubiquitin c-terminal hydrolases in oncogenesis. Biochim Biophys Acta 1806: 1-6, 2010.
10. Hasan W, Jama A, Donohue T, Wernli G, Onyszchuk G, Al-Hafez B, Bilgen M, Smith PG. Sympathetic hyperinnervation and inflammatory cell NGF synthesis following myocardial infarction in rats. Brain Res 1124: 142-154, 2006.
11. Huang BS, Ahmadi S, Ahmad M, White RA, Leenen FH. Central neuronal activation and pressor responses induced by circulating ANG II: role of the brain aldosterone-"ouabain" pathway. Am J Physiol Heart Circ Physiol 299: H422-H430, 2010.
12. Huang BS, Leenen FH. Blockade of brain mineralocorticoid receptors or Na+ channels prevents sympathetic hyperactivity and improves cardiac function in rats post-MI. Am J Physiol Heart Circ Physiol 288: H2491-H2497, 2005.
13. Huang BS, Leenen FH. The brain renin-angiotensin-aldosterone system: a major mechanism for sympathetic hyperactivity and left ventricular remodeling and dysfunction after myocardial infarction. Curr Heart Fail Rep 6: 81-88, 2009.
14. Jardine DL, Charles CJ, Ashton RK, Bennett SI, Whitehead M, Frampton CM, Nicholls MG. Increased cardiac sympathetic nerve activity following acute myocardial infarction in a sheep model. J Physiol 565: 325-333, 2005.
15. Jardine DL, Charles CJ, Frampton CM, Richards AM. Cardiac sympathetic nerve activity and ventricular fibrillation during acute myocardial infarction in a conscious sheep model. Am J Physiol Heart Circ Physiol 293: H433-H439, 2007.
16. Kaye DM, Lambert GW, Lefkovits J, Morris M, Jennings G, Esler MD. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol 23: 570-578, 1994.
17. Kimura K, Ieda M, Fukuda K. Development, maturation, and transdifferentiation of cardiac sympathetic nerves. Circ Res 110: 325-336, 2012.
18. Kumer SC, Vrana KE. Intricate regulation of tyrosine hydroxylase activity and gene expression. J Neurochem 67: 443-462, 1996.
19. Lal A, Veinot JP, Leenen FH. Critical role of CNS effects of aldosterone in cardiac remodeling post-myocardial infarction in rats. Cardiovasc Res 64: 437-447, 2004.
20. Lee TM, Chen CC, Chung TH, Chang NC. Effect of sildenafil on ventricular arrhythmias in post-infarcted rat hearts. Eur J Pharmacol 690: 124-132, 2012.
21. Lee TM, Chen CC, Hsu YJ. Differential effects of NADPH oxidase and xanthine oxidase inhibition on sympathetic reinnervation in postinfarct rat hearts. Free Radic Biol Med 50: 1461-1470, 2011.
22. Lee TM, Lai PY, Chang NC. Effect of N-acetylcysteine on sympathetic hyperinnervation in post-infarcted rat hearts. Cardiovasc Res 85: 137-146, 2010.
23. Leenen FH, Skarda V, Yuan B, White R. Changes in cardiac ANG II postmyocardial infarction in rats: effects of nephrectomy and ACE inhibitors. Am J Physiol Heart Circ Physiol 276: H317-H325, 1999.
24. Leenen FH, Yuan B, Huang BS. Brain "ouabain" and angiotensin II contribute to cardiac dysfunction after myocardial infarction. Am J Physiol Heart Circ Physiol 277: H1786-H1792, 1999.
25. Li W, Knowlton D, Van Winkle DM, Habecker BA. Infarction alters both the distribution and noradrenergic properties of cardiac sympathetic neurons. Am J Physiol Heart Circ Physiol 286: H2229-H2236, 2004.
26. Mandela P, Ordway GA. The norepinephrine transporter and its regulation. J Neurochem 97: 310-333, 2006.
27. Melikian HE, Ramamoorthy S, Tate CG, Blakely RD. Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition. Mol Pharmacol 50: 266-276, 1996.
28. Oh YS, Jong AY, Kim DT, Li H, Wang C, Zemljic-Harpf A, Ross RS, Fishbein MC, Chen PS, Chen LS. Spatial distribution of nerve sprouting after myocardial infarction in mice. Heart Rhythm 3: 728-736, 2006.
29. Olerud JE, Chiu DS, Usui ML, Gibran NS, Ansel JC. Protein gene product 9.5 is expressed by fibroblasts in human cutaneous wounds. J Invest Dermatol 111: 565-572, 1998.
30. Osaka H, Wang YL, Takada K, Takizawa S, Setsuie R, Li H, Sato Y, Nishikawa K, Sun YJ, Sakurai M, Harada T, Hara Y, Kimura I, Chiba S, Namikawa K, Kiyama H, Noda M, Aoki S, Wada K. Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum Mol Genet 12: 1945-1958, 2003.
31. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 20: 248-254, 1992.
32. Parrish DC, Alston EN, Rohrer H, Nkadi P, Woodward WR, Schutz G, Habecker BA. Infarction-induced cytokines cause local depletion of tyrosine hydroxylase in cardiac sympathetic nerves. Exp Physiol 95: 304-314, 2010.
33. Parrish DC, Gritman K, Van Winkle DM, Woodward WR, Bader M, Habecker BA. Postinfarct sympathetic hyperactivity differentially stimulates expression of tyrosine hydroxylase and norepinephrine transporter. Am J Physiol Heart Circ Physiol 294: H99-H106, 2008.
34. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, Braunwald E. Myocardial infarct size and ventricular function in rats. Circ Res 44: 503-512, 1979.
35. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M; Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348: 1309-1321, 2003.
36. Raedschelders K, Ansley DM, Chen DD. The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion. Pharmacol Ther 133: 230-255, 2012.
37. Ramchandra R, Hood SG, Watson AM, Allen AM, May CN. Central angiotensin type 1 receptor blockade decreases cardiac but not renal sympathetic nerve activity in heart failure. Hypertension 59: 634-641, 2012.
38. Rundqvist B, Elam M, Bergmann-Sverrisdottir Y, Eisenhofer G, Friberg P. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 95: 169-175, 1997.
39. Savchenko V, Sung U, Blakely RD. Cell surface trafficking of the antidepressant-sensitive norepinephrine transporter revealed with an ectodomain antibody. Mol Cell Neurosci 24: 1131-1150, 2003.
40. Schwenke DO, Tokudome T, Kishimoto I, Horio T, Shirai M, Cragg PA, Kangawa K. Early ghrelin treatment after myocardial infarction prevents an increase in cardiac sympathetic tone and reduces mortality. Endocrinology 149: 5172-5176, 2008.
41. Shen H, Sikorska M, Leblanc J, Walker PR, Liu QY. Oxidative stress regulated expression of ubiquitin carboxyl-terminal hydrolase-L1: role in cell survival. Apoptosis 11: 1049-1059, 2006.
42. Spiegel K, Kremer NE, Kessler JA. Differences in the effects of membrane depolarization on levels of preprosomatostatin mRNA and tyrosine hydroxylase mRNA in rat sympathetic neurons in vivo and in culture. Brain Res Mol Brain Res 5: 23-29, 1989.
43. Sun Y, Weber KT. Infarct scar: a dynamic tissue. Cardiovasc Res 46: 250-256, 2000.
44. Sun Y, Zhang JQ, Zhang J, Lamparter S. Cardiac remodeling by fibrous tissue after infarction in rats. J Lab Clin Med 135: 316-323, 2000.
45. Swissa M, Zhou S, Gonzalez-Gomez I, Chang CM, Lai AC, Cates AW, Fishbein MC, Karagueuzian HS, Chen PS, Chen LS. Long-term subthreshold electrical stimulation of the left stellate ganglion and a canine model of sudden cardiac death. J Am Coll Cardiol 43: 858-864, 2004.
46. Tan J, Wang H, Leenen FH. Increases in brain and cardiac AT1 receptor and ACE densities after myocardial infarct in rats. Am J Physiol Heart Circ Physiol 286: H1665-H1671, 2004.
47. Vargas MR, Pehar M, Cassina P, Estevez AG, Beckman JS, Barbeito L. Stimulation of nerve growth factor expression in astrocytes by peroxynitrite. In Vivo 18: 269-274, 2004.
48. Weekes J, Morrison K, Mullen A, Wait R, Barton P, Dunn MJ. Hyperubiquitination of proteins in dilated cardiomyopathy. Proteomics 3: 208-216, 2003.
49. Wei SG, Yu Y, Zhang ZH, Weiss RM, Felder RB. Angiotensin IItriggered p44/42 mitogen-activated protein kinase mediates sympathetic excitation in heart failure rats. Hypertension 52: 342-350, 2008.
50. Wernli G, Hasan W, Bhattacherjee A, van Rooijen N, Smith PG. Macrophage depletion suppresses sympathetic hyperinnervation following myocardial infarction. Basic Res Cardiol 104: 681-693, 2009.
51. Yuan MJ, Huang CX, Tang YH, Wang X, Huang H, Chen YJ, Wang T. A novel peptide ghrelin inhibits neural remodeling after myocardial infarction in rats. Eur J Pharmacol 618: 52-57, 2009.
52. Zhou S, Chen LS, Miyauchi Y, Miyauchi M, Kar S, Kangavari S, Fishbein MC, Sharifi B, Chen PS. Mechanisms of cardiac nerve sprouting after myocardial infarction in dogs. Circ Res 95: 76-83, 2004.
53. Zigmond RE, Chalazonitis A, Joh T. Preganglionic nerve stimulation increases the amount of tyrosine hydroxylase in the rat superior cervical ganglion. Neurosci Lett 20: 61-65, 1980.